Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement

A new technetium-chelating agent based on a triamide monomercaptide tetradentate set of donor groups, mercaptoacetylglycylglycylglycine (MAG3), was synthesized and evaluated. Chelation with /sup 99m/Tc resulted in a single radiochemical product as expected. Studies in mice of [/sup 99m/Tc]MAG3 indicated excretion rates faster than omicron-iodohippurate (OIH) both in normal and in probenecid treated animals. Specificity for renal excretion was essentially complete. Clearance studies in rats resulted in 2.84 ml/min/100 g for [/sup 99m/Tc]MAG3, 2.17 for OIH, and 1.29 for [125I]iothalamate. Extraction efficiencies were 85% for [/sup 99m/Tc]MAG3, 69% for OIH and 39% for [125I]iothalamate. Probenicid depressed the clearance both of [/sup 99m/Tc]MAG3 and OIH at 25 and 50 mg/kg/hr, but to a greater extent with [/sup 99m/Tc]MAG3. The greater effect is offset, however, by the larger fraction secreted by the renal tubular cells. The animal results suggest that [/sup 99m/Tc]MAG3 may be a useful alternative to [131I]OIH